# Problem Statement

# SignalTrace

## The Problem

Pharmacovigilance teams work with very large volumes of adverse-event reports. One important task is detecting unusual associations between a drug and an adverse event that may represent a **candidate safety signal**.

Official FDA FAERS quarterly data provides a structured historical source of adverse-event reports. Statistical signal-detection methods can analyze this data to identify drug-event combinations that deserve further investigation.

However, signal detection is only the first step.

After a candidate signal is detected, reviewers still need to understand:

- Why was this drug-event pair flagged?
- How strong is the statistical evidence?
- How many reports support it?
- Are some reports potentially duplicated?
- Is case information incomplete?
- Is there a trend over time?
- What evidence should be investigated next?
- Which regulatory documents may be relevant?
- Does an existing document already contain related safety information?

These tasks can involve separate systems, manual review, spreadsheets, safety reports, and regulatory documents.

---

## Core Gap

The traditional flow often looks like:

```text
Adverse Event Data
        ↓
Statistical Signal Detection
        ↓
Candidate Signal
        ↓
Manual Investigation
        ↓
Manual Regulatory Review
```

The major opportunity is to create a connected workflow:

```text
Historical FDA Data
        ↓
Candidate Signal
        ↓
Evidence Investigation
        ↓
AI Explanation
        ↓
Potential Regulatory Impact
        ↓
Document Analysis
        ↓
Human Review
```

---

## Problem Statement

**Pharmacovigilance teams can identify candidate safety signals from adverse-event data, but investigating the evidence behind those signals and connecting them to potentially impacted regulatory documents can still require fragmented and manual workflows. SignalTrace aims to provide a connected decision-support workflow that helps users move from candidate signal detection to structured evidence review and potential regulatory document assessment.**

---

## Scope and Safety Boundary

SignalTrace is a decision-support platform.

It does not:

- Prove causality.
- Diagnose patients.
- Declare that a medicine is unsafe.
- Replace pharmacovigilance professionals.
- Make final regulatory decisions.
- Automatically modify regulatory documents.
- Automatically submit information to regulators.

All important findings require qualified human review.
